These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1501670)

  • 1. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Huh M; Davis W
    N Engl J Med; 1992 Sep; 327(11):817. PubMed ID: 1501670
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Raphael JC; Chastang C; Chevret S; Gajdos P
    N Engl J Med; 1992 Sep; 327(11):816; author reply 817. PubMed ID: 1501669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of acute Guillain-Barré syndrome. A national multicenter study].
    Kloss TM; Haupt WF; Philipp T; Diener HC
    Nervenarzt; 1994 Dec; 65(12):881-3. PubMed ID: 7854512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome.
    Rajah A
    Anaesthesia; 1992 Mar; 47(3):220-2. PubMed ID: 1566990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of intravenous immunoglobulins in Guillain-Barré syndrome].
    Forrett-Kaminsky MC; Scherer C; Bemer M; Robert V; Steinbach G; Poussel JF
    Presse Med; 1991 Oct; 20(31):1516. PubMed ID: 1835056
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
    Imai N; Miyata K; Terayama Y; Ishihara N
    Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)].
    Hartung HP; Gold R; Zielasek J; Archelos JJ; Toyka KV
    Nervenarzt; 1994 Dec; 65(12):807-18. PubMed ID: 7854501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The place of high dose immunoglobulins in the treatment of Guillain-Barré patients based upon the dutch trial.
    van der Meché FG
    Wien Klin Wochenschr Suppl; 1991; 190():17-8. PubMed ID: 1771902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial experiences in the use of intravenous immunoglobulins in Guillain-Barré-Strohl syndrome].
    Ceccarelli M; Pifferi M; Simoni F; Lupetti L; Ughi C
    Pediatr Med Chir; 1987; 9(6):719-21. PubMed ID: 3444744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of the Guillain-Barre syndrome with intravenous gammaglobulin. Presentation of a case].
    Barriales V; Velasco L; Moral A; Sánchez Navarro J
    Med Clin (Barc); 1990 Mar; 94(10):399. PubMed ID: 1692387
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapse in Guillain-Barré syndrome after treatment with human immune globulin.
    Irani DN; Cornblath DR; Chaudhry V; Borel C; Hanley DF
    Neurology; 1993 May; 43(5):872-5. PubMed ID: 8492939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1992 Jul; 32(1):94-7. PubMed ID: 1642477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do corticosteroids influence the disease course or mortality of Guillain Barre syndrome?
    Mehndiratta MM
    J Assoc Physicians India; 1996 Jun; 44(6):431. PubMed ID: 9282570
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children.
    Vallée L; Dulac O; Nuyts JP; Leclerc F; Vamecq J
    Neuropediatrics; 1993 Aug; 24(4):235-6. PubMed ID: 8232785
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
    Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome.
    McGhee B; Jarjour IT
    Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.